Sernova Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SVA.TO research report →
Price Chart
About the company
Sernova Corp. is a Canadian clinical-stage enterprise specializing in the development and commercialization of groundbreaking regenerative medicine therapies. Its core endeavors revolve around its proprietary Cell Pouch system and associated technologies, which encompass specialized therapeutic cells and mechanisms for localized cellular immune protection.
- CEO
- Jonathan N. Rigby
- IPO
- 1999
- Employees
- 8
- HQ
- Mississauga, ON, CA
Get TickerSpark's AI analysis on SVA.TO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $41.54M
- P/E
- -3.13
- Fwd P/E
- 0.48
- PEG
- -0.04
- P/S
- 0.00
- P/B
- -4.01
- EV/EBITDA
- -4.20
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 55.85%
- ROIC
- 142.10%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-342,591+36.6%
- Op Income
- $-15,124,648
- Net Income
- $-15,743,466+51.1%
- EPS
- $-0.05+52.0%
- OCF Growth
- +42.3%
- FCF Growth
- +42.3%
- 52W High
- $0.20
- 52W Low
- $0.10
- 50D MA
- $0.13
- 200D MA
- $0.15
- Beta
- 0.64
- RSI (14)
- 46
- Avg Volume
- 124.31K
No earnings-call transcripts are available for SVA.TO yet.
- Free Float
- 86.5%
- Shares Outstanding
- 377.64M
- Float Shares
- 326.77M
Our SVA.TO coverage
Recent articles, reports, and earnings notes.
No research on SVA.TO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SVA.TO report →